Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Michael T. Williams

9 papers in the library · 286 citations · publishing 2003-2016

Papers

Exposure to 3,4‐methylenedioxymethamphetamine (MDMA) on postnatal days 11–20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning

International Journal of Developmental Neuroscience August 1, 2004 Charles V. Vorhees, Tracy M. Reed, Matthew R. Skelton et al. 76 citations

Rats exposed to MDMA on postnatal days 11–20 showed consistent impairments in spatial learning and memory in the Morris water maze when tested on that maze first, with longer latencies, longer path lengths, and greater cumulative distance from the goal compared to saline controls. On probe trials, MDMA-treated animals that received the water maze first had increased distance from the target site. No MDMA effects were observed on cued trials, straight channel swimming, or working memory, indicating the drug did not impair swimming ability or basic task skills. No MDMA effects were found on the Barnes maze, though interpretation was limited by poor performance on that task.

Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress

Brain Research March 25, 2003 Michael T. Williams, Laronda L. Morford, Sandra L. Wood et al. 66 citations

Rats given MDMA from postnatal days 11 to 20 showed lasting deficits in spatial learning and memory, even when growth restriction from the drug was matched by raising rats in larger litters. Males exposed to MDMA took longer and made more errors in the Cincinnati water maze than control males. In the Morris water maze, MDMA-treated rats of both sexes were impaired during initial learning. Only females showed deficits when the platform was first moved, but both sexes were impaired after a second move with a smaller platform. No differences appeared in swimming ability, cued navigation, or stress hormone responses. Growth retardation, injections, or litter size did not account for the learning impairments.

(+/–)3,4-Methylenedioxymethamphetamine (MDMA) Dose-Dependently Impairs Spatial Learning in the Morris Water Maze after Exposure of Rats to Different Five-Day Intervals from Birth to Postnatal Day Twenty

Developmental Neuroscience January 1, 2009 Charles V. Vorhees, Tori L. Schaefer, Matthew R. Skelton et al. 40 citations

Treating rat pups with MDMA during different preweaning periods (postnatal days 1–5, 6–10, 11–15, or 16–20) produced lasting effects. The three highest doses (15, 20, and 25 mg/kg) reduced spontaneous locomotor activity during the first 10 minutes of testing, especially when given on days 1–5 or 6–10. All MDMA-treated groups showed impaired allocentric learning in the Morris water maze during both acquisition and reversal phases; the two highest doses also impaired performance on the small platform phase. No effects were found on anxiety, novel object recognition, or egocentric learning, though a nonsignificant trend appeared. The results indicate that allocentric and egocentric learning have different exposure-duration sensitivities and that the stress hyporesponsive period is not critical for MDMA's effects on allocentric learning.

Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.

Psychopharmacology June 1, 2009 Matthew R. Skelton, Tori L. Schaefer, Nicole R Herring et al. 31 citations

Treating young rats with either MDMA or the club drug 5-MeO-DIPT from postnatal days 11 to 20 caused lasting cognitive and behavioral changes, but the patterns differed between the two drugs. MDMA-treated animals showed increased anxiety, deficits in spatial and path integration learning, and memory problems. 5-MeO-DIPT-treated animals had spatial learning deficits but no impairments in spatial memory or path integration learning, and they were hyperactive when given a challenge dose of methamphetamine. The findings indicate that developmental exposure to either drug produces distinct behavioral effects.

(±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

J Comp Neurol August 1, 2012 Ann M. Hemmerle, Jonathan W. Dickerson, Nicole R Herring et al. 29 citations

A single dose of MDMA (ecstasy) alters the expression of neurotrophins and their receptors in several regions of the adult rat brain, suggesting that the drug can influence brain plasticity and potentially contribute to its long-term effects.

Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA

The International Journal of Neuropsychopharmacology January 11, 2013 Tori L. Schaefer, Curtis E. Grace, A Braun et al. 24 citations

In rats, treatment with the recreational drug MDMA during a developmental period equivalent to the human third trimester causes long-term spatial and egocentric learning and memory deficits, along with serotonin reductions. Pretreatment with the antidepressant citalopram, a selective serotonin reuptake inhibitor, did not prevent these cognitive deficits. Unexpectedly, citalopram alone produced learning deficits as severe as those caused by MDMA. These are the first findings showing cognitive impairments from developmental exposure to a selective serotonin reuptake inhibitor, suggesting the need for further research on the long-term safety of antidepressants during pregnancy.

Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.

Neurotoxicology and Teratology January 1, 2010 Devon L Graham, Nicole R Herring, Tori L. Schaefer et al. 13 citations

Acute exposure to the club drugs MDMA (Ecstasy) and Foxy increases the stress hormone corticosterone in rats at all ages tested—preweaning, juvenile, and adulthood. Blood glucose also rises at all stages except in juveniles. No differences were found between males and females. These hormonal and metabolic changes may contribute to the behavioral and cognitive impairments previously linked to these drugs.

Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

The open neuropsychopharmacology journal January 1, 2012 Devon L Graham, Nicole R Herring, Tori L. Schaefer et al. 4 citations

Binge doses of methamphetamine (MA) cause brief epileptiform brain activity in about half of rats and longer seizures in some, while MDMA produces no significant brain-wave abnormalities or muscle jerks. The drug Foxy (5-MeO-DIPT) triggers seizures in all rats shortly after the first dose, with muscle jerks appearing soon after injection. These effects were observed in male rats implanted with cortical electrodes and given four injections of each drug (10 mg/kg every two hours), a regimen that mimics the neurochemical changes seen in chronic users. The findings indicate that MDMA does not increase EEG abnormalities under these conditions, whereas MA and especially Foxy produce severe brain-activity disturbances.

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine

Toxicology Reports October 11, 2016 Michael T. Williams, Matthew R. Skelton, Ian D. Longacre et al. 3 citations

Rats given MDMA during a period of brain development equivalent to late human pregnancy showed lasting changes in brain cell structure. In the nucleus accumbens, dendrites were shorter with fewer spines. In the dentate gyrus, dendritic length decreased but spine density increased. In the entorhinal cortex, both basilar and apical dendritic lengths were reduced. These structural changes occurred in brain regions linked to learning and memory, matching previously observed cognitive deficits in MDMA-exposed animals.